Neuroreport 11, 2885-2888, (2000). Romieu, P., Martin-Fardon, R., & Maurice, T View abstract in PubMed Post navigationPreviousPrevious post:Animal models of Alzheimer’s disease and evaluation of anti-dementia drugs.NextNext post:Effects of sigma receptor agonists on the impairment of spontaneous alternation behavior and decrease of cyclic GMP level induced by nitric oxide synthase inhibitors in mice.Related PostsAnavex Life Sciences to Present at the 30th Annual ROTH ConferenceMarch 9, 2018Anavex Life Sciences to Present New Preclinical Data at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (ASENT)March 7, 2018Anavex Life Sciences to Present at Cowen and Company 38th Annual Health Care ConferenceMarch 6, 2018Anavex Life Sciences Strengthens Management Team and Board of DirectorsMarch 5, 2018
Anavex Life Sciences to Present New Preclinical Data at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (ASENT)March 7, 2018
